Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Article Menu
Export Article
More by Authors Links
Article Data
- Views 4406
- Dowloads 114
Review
Open AccessTransfusion related acute lung injury (TRALI)
Transfusion related acute lung injury (TRALI)
1Department of Anesthesiology, Reanimatology and Intensive Care University Hospital Zagreb
2,Croatian Institute of Transfusion Medicine Hospital Transfusion Service in Clinical
*Corresponding Author(s): TAJANA ZAH E-mail: tajanazah@yahoo.com
Abstract
Transfusion-related acute lung injury (TRALI) is a complication following transfusion of blood products and is potentially a life-threatening adverse event of transfusion. The first case of fatal pulmonary edema following transfusion was reported in the 1950s. In recent time, TRALI has developed from an almost unknown transfusion reaction to the most common cause of transfusion related major morbidities and fatalities. A clinical definition of TRALI was established in 2004, based on acute respiratory distress which has temporal association with transfusion of blood components. In 2008 a distinction between classic and delayed syndrome was proposed. However, pathophysiology of TRALI still remains controversial. A number of different models were proposed to explain the pathogenesis. The two, presently most accepted models, are not mutually exclusive. The first is the antibody mediated model and the second is the two-event model.
In this review article the definition of TRALI, patient predisposition, treatment, prevention and reporting guidelines are exa-mined. The current knowledge on the topic TRALI is summarized.
Keywords
transfusion, acute lung injury
Cite and Share
TAJANA ZAH,JASNA MESARIĆ,VIŠNJA MAJERIĆ-KOGLER. Transfusion related acute lung injury (TRALI). Signa Vitae. 2009. 4(2);8-11.
References
3. Graul A, Heiden M, Gräf K, Keller-Stanislawski B. Hämovigilanz in Deutschland – Berichte an das Paul-Ehrlich-Institut über Verdachtsfälle von Transfusionsreaktionen im Beobachtungszeitraum Januar 1995 bis Dezember 2002.Transfus Med Hemother 2003;30:232–8.
4. Joergensen J, Taaning E. DART – a volunteer system of haemovigillance in Denmark. Transfusion Alternatives. Transfus Med 2003;5:260–4.
5. Robillard P, Nawej KI, Chapdeleine A, Poole J, Garneau N. Adverse transfusion reactions with respiratory signs and symptoms including TRALI in the Quebec Haemovigillance system: 2000–2003.Transfusion 2004;44:23-9.
6. Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions NY State. J Med 1951;51:2399–402.
7. Popovsky MA, Abel MP, Moore SB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983;128:185–9.
8. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion- related acute lung injury. Transfusion 1985;25(6):573-7.
9. Rizk A, Gorson KC, Kenney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 2001;41:264–8.
10. Toy P, Popovsky MA. Transfusion-related acute lung injury: Definition and review. Crit Care Med 2005;33:721–6.
11. Silliman CC, Paterson AJ, Dickey WO, Stroneck DF, Popovsky MA, Caldwell SA, et al. The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study. Transfusion 1997;37:719–26.
12. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion 2003; 43:1053–9.
13. Silliman CC, Boskkov L, Mehdizadehkashi, Elzi DJ, Dickey WO, Podlosky L, et al. Transfusion related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-62.
14. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA. Proceedings of a consensus conference: towards and under-standing of TRALI. Transfus Med Rev 2005;19:2–31.
15. Jawa RS, Anillo S, Kulaylat MN. Transfusion-Related Acute Lung Injury. J Int Care Med 2008;23(2):109-21.
Submission Turnaround Time
Top